Scientific production from 2010 to 2018 about the quality control of plant species included in the Brazilian National List of Essential Medicines

Detalhes bibliográficos
Autor(a) principal: Rodrigues, Lucas Oliveira
Data de Publicação: 2021
Outros Autores: Mourão, Samanta Cardozo, Gouvêa, Marcos Martins
Tipo de documento: Artigo
Idioma: por
eng
Título da fonte: Vigilância Sanitária em Debate
Texto Completo: https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1547
Resumo: Introduction: The Brazilian Ministry of Health established the National List of Medicinal Plants of Interest to the Unified Health System (Renisus) to encourage scientific  research related to a list of 71 plant species with potential to generate new productsfor the public health system. However, only 12 of these species are contemplated by the Brazilian National List of Essential Medicines (Rename) and therefore have their respective phytomedicines offered at SUS. In addition, 3 of them are not contemplated in the Brazilian Pharmacopoeia. Objective: This work aims to indicate the possibility of using the available references to elaborate and include the missing monographs in the Brazilian Pharmacopoeia; as well as to assess whether the main government policy to  encourage research in the area influenced Brazilian scientific production considering the studied profile. Method: A longitudinal retrospective study was carried out using the Web of Science and Scopus databases regarding the quality control of the 12 plant species contemplated in the Rename by different analytical techniques considering the pre andpost-Renisus periods (pre and post-2010). Results: All evaluated species presented scientific articles describing analytical methods to determine their constituents. Among the evaluated species, 67% had low individual nominal growth (≤ 8 articles) in the pre and post Renisus periods, while the rest showed greater growth (≥ 19 articles). Conclusions: There are available references in the literature with potential analytical methods for the elaboration of the missing pharmacopoeial monographs in the Brazilian compendium. However, the incentive policies may not have had significantly influenced the studied fraction of the Brazilian scientific production.
id FIOCRUZ-9_6aef378cba5f09791fe98cbf2de53fc5
oai_identifier_str oai:ojs.visaemdebate.incqs.fiocruz.br:article/1547
network_acronym_str FIOCRUZ-9
network_name_str Vigilância Sanitária em Debate
repository_id_str
spelling Scientific production from 2010 to 2018 about the quality control of plant species included in the Brazilian National List of Essential MedicinesProdução científica de 2010 a 2018 sobre o controle de qualidade de espécies vegetais incluídas na Relação Nacional de Medicamentos EssenciaisPlantas medicinaisFitoterápicosAnálise bibliométricaSistema Único de SaúdeRENISUSMedicinal plantsPhytomedicinesBibliometric analysisBrazilian Unified Health SystemRENISUSIntroduction: The Brazilian Ministry of Health established the National List of Medicinal Plants of Interest to the Unified Health System (Renisus) to encourage scientific  research related to a list of 71 plant species with potential to generate new productsfor the public health system. However, only 12 of these species are contemplated by the Brazilian National List of Essential Medicines (Rename) and therefore have their respective phytomedicines offered at SUS. In addition, 3 of them are not contemplated in the Brazilian Pharmacopoeia. Objective: This work aims to indicate the possibility of using the available references to elaborate and include the missing monographs in the Brazilian Pharmacopoeia; as well as to assess whether the main government policy to  encourage research in the area influenced Brazilian scientific production considering the studied profile. Method: A longitudinal retrospective study was carried out using the Web of Science and Scopus databases regarding the quality control of the 12 plant species contemplated in the Rename by different analytical techniques considering the pre andpost-Renisus periods (pre and post-2010). Results: All evaluated species presented scientific articles describing analytical methods to determine their constituents. Among the evaluated species, 67% had low individual nominal growth (≤ 8 articles) in the pre and post Renisus periods, while the rest showed greater growth (≥ 19 articles). Conclusions: There are available references in the literature with potential analytical methods for the elaboration of the missing pharmacopoeial monographs in the Brazilian compendium. However, the incentive policies may not have had significantly influenced the studied fraction of the Brazilian scientific production.Introdução: O Ministério da Saúde elaborou a Relação Nacional de Plantas Medicinais de Interesse ao Sistema Único de Saúde (Renisus) para incentivar a pesquisa científica de 71 espécies vegetais com potencial para gerar produtos para o Sistema Único de Saúde. Destas, 12 constam na Relação Nacional de Medicamentos Essenciais (Rename) e, portanto, têmseus respectivos fitoterápicos ofertados no sistema público. Entretanto, três ainda não apresentam monografias na Farmacopeia Brasileira. Objetivo: Avaliar quantitativamente a produção científica sobre o controle de qualidade das 12 espécies da Rename, demonstrar a possibilidade de utilização das referências já disponíveis na elaboração e inclusão das monografias ainda não contempladas no compêndio nacional e avaliar se a principal política governamental de incentivo da área influenciou a produção científica brasileira considerando o recorte estudado. Método: O levantamento dos dados foi realizado a partir de um estudo longitudinal retrospectivo, considerando o controle de qualidade das 12 espécies vegetais da Rename por diferentes técnicas analíticas nos períodos pré e pós-Renisus (pré e pós-2010), utilizando as bases de dados Web of Science e Scopus. Resultados: Todas as espécies avaliadas apresentaram artigos científicos descrevendo métodos analíticos para a determinação de seus constituintes. Considerando a produção científica brasileira, 67% das espécies vegetais apresentaram baixo crescimento nominal individual (≤ oito artigos) no período posterior à promulgação da Renisus, enquanto orestante apresentou maior crescimento (≥ 19 artigos). Conclusões: As espécies ainda não contempladas na Farmacopeia Brasileira apresentaram referências na literatura com potenciais métodos analíticos para elaboração de futuras monografias farmacopeicas. Entretanto, as políticas de incentivo podem não ter influenciado significativamente a fração estudada da produção científica brasileira.Instituto Nacional de Controle de Qualidade em Saúde2021-05-31info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion"Peer-reviewed article""Artículo revisado por pares""Artigo avaliado pelos pares"application/pdfapplication/pdfhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/154710.22239/2317-269x.01547Health Surveillance under Debate: Society, Science & Technology ; Vol. 9 No. 2 (2021): May; 21-27Vigilancia en Salud en Debate: Sociedad, Ciencia y Tecnología; Vol. 9 Núm. 2 (2021): Puede; 21-27Vigil Sanit Debate, Rio de Janeiro; v. 9 n. 2 (2021): Maio; 21-272317-269Xreponame:Vigilância Sanitária em Debateinstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZporenghttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1547/1243https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1547/1359Copyright (c) 2020 Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia (Health Surveillance under Debate: Society, Science & Technology) – Visa em Debatehttps://creativecommons.org/licenses/by-nc/4.0info:eu-repo/semantics/openAccessRodrigues, Lucas OliveiraMourão, Samanta CardozoGouvêa, Marcos Martins2023-06-27T15:13:26Zoai:ojs.visaemdebate.incqs.fiocruz.br:article/1547Revistahttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebatePUBhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/oaiincqs.visaemdebate@fiocruz.br || gisele.neves@fiocruz.br2317-269X2317-269Xopendoar:2023-06-27T15:13:26Vigilância Sanitária em Debate - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.none.fl_str_mv Scientific production from 2010 to 2018 about the quality control of plant species included in the Brazilian National List of Essential Medicines
Produção científica de 2010 a 2018 sobre o controle de qualidade de espécies vegetais incluídas na Relação Nacional de Medicamentos Essenciais
title Scientific production from 2010 to 2018 about the quality control of plant species included in the Brazilian National List of Essential Medicines
spellingShingle Scientific production from 2010 to 2018 about the quality control of plant species included in the Brazilian National List of Essential Medicines
Rodrigues, Lucas Oliveira
Plantas medicinais
Fitoterápicos
Análise bibliométrica
Sistema Único de Saúde
RENISUS
Medicinal plants
Phytomedicines
Bibliometric analysis
Brazilian Unified Health System
RENISUS
title_short Scientific production from 2010 to 2018 about the quality control of plant species included in the Brazilian National List of Essential Medicines
title_full Scientific production from 2010 to 2018 about the quality control of plant species included in the Brazilian National List of Essential Medicines
title_fullStr Scientific production from 2010 to 2018 about the quality control of plant species included in the Brazilian National List of Essential Medicines
title_full_unstemmed Scientific production from 2010 to 2018 about the quality control of plant species included in the Brazilian National List of Essential Medicines
title_sort Scientific production from 2010 to 2018 about the quality control of plant species included in the Brazilian National List of Essential Medicines
author Rodrigues, Lucas Oliveira
author_facet Rodrigues, Lucas Oliveira
Mourão, Samanta Cardozo
Gouvêa, Marcos Martins
author_role author
author2 Mourão, Samanta Cardozo
Gouvêa, Marcos Martins
author2_role author
author
dc.contributor.author.fl_str_mv Rodrigues, Lucas Oliveira
Mourão, Samanta Cardozo
Gouvêa, Marcos Martins
dc.subject.por.fl_str_mv Plantas medicinais
Fitoterápicos
Análise bibliométrica
Sistema Único de Saúde
RENISUS
Medicinal plants
Phytomedicines
Bibliometric analysis
Brazilian Unified Health System
RENISUS
topic Plantas medicinais
Fitoterápicos
Análise bibliométrica
Sistema Único de Saúde
RENISUS
Medicinal plants
Phytomedicines
Bibliometric analysis
Brazilian Unified Health System
RENISUS
description Introduction: The Brazilian Ministry of Health established the National List of Medicinal Plants of Interest to the Unified Health System (Renisus) to encourage scientific  research related to a list of 71 plant species with potential to generate new productsfor the public health system. However, only 12 of these species are contemplated by the Brazilian National List of Essential Medicines (Rename) and therefore have their respective phytomedicines offered at SUS. In addition, 3 of them are not contemplated in the Brazilian Pharmacopoeia. Objective: This work aims to indicate the possibility of using the available references to elaborate and include the missing monographs in the Brazilian Pharmacopoeia; as well as to assess whether the main government policy to  encourage research in the area influenced Brazilian scientific production considering the studied profile. Method: A longitudinal retrospective study was carried out using the Web of Science and Scopus databases regarding the quality control of the 12 plant species contemplated in the Rename by different analytical techniques considering the pre andpost-Renisus periods (pre and post-2010). Results: All evaluated species presented scientific articles describing analytical methods to determine their constituents. Among the evaluated species, 67% had low individual nominal growth (≤ 8 articles) in the pre and post Renisus periods, while the rest showed greater growth (≥ 19 articles). Conclusions: There are available references in the literature with potential analytical methods for the elaboration of the missing pharmacopoeial monographs in the Brazilian compendium. However, the incentive policies may not have had significantly influenced the studied fraction of the Brazilian scientific production.
publishDate 2021
dc.date.none.fl_str_mv 2021-05-31
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
"Peer-reviewed article"
"Artículo revisado por pares"
"Artigo avaliado pelos pares"
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1547
10.22239/2317-269x.01547
url https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1547
identifier_str_mv 10.22239/2317-269x.01547
dc.language.iso.fl_str_mv por
eng
language por
eng
dc.relation.none.fl_str_mv https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1547/1243
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1547/1359
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by-nc/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Instituto Nacional de Controle de Qualidade em Saúde
publisher.none.fl_str_mv Instituto Nacional de Controle de Qualidade em Saúde
dc.source.none.fl_str_mv Health Surveillance under Debate: Society, Science & Technology ; Vol. 9 No. 2 (2021): May; 21-27
Vigilancia en Salud en Debate: Sociedad, Ciencia y Tecnología; Vol. 9 Núm. 2 (2021): Puede; 21-27
Vigil Sanit Debate, Rio de Janeiro; v. 9 n. 2 (2021): Maio; 21-27
2317-269X
reponame:Vigilância Sanitária em Debate
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Vigilância Sanitária em Debate
collection Vigilância Sanitária em Debate
repository.name.fl_str_mv Vigilância Sanitária em Debate - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv incqs.visaemdebate@fiocruz.br || gisele.neves@fiocruz.br
_version_ 1797042045930438656